FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126665195> ?p ?o ?g. }

• W2126665195 endingPage "276" @default.
• W2126665195 startingPage "266" @default.
• W2126665195 abstract "Direct experimental safety comparisons of Xa coagulation factor direct inhibitors, apixaban and rivaroxaban, on their approved therapeutic indications have not been identified. Due to recently raised safety concerns, a meta-analysis was carried out pooling data from studies identified on a Medline and Cochrane Library search in order to better evaluate the safety profile of both drugs. Abstracts from scientific meetings were also searched from 2003 to 2011. Primary and secondary outcome measures were major bleeding and total bleeding, respectively. Relative risks (RRs) were estimated using random effects models and statistical heterogeneity was estimated with I(2) statistics. Of the 160 screened publications, 12 clinical trials were included in which enoxaparin was the active control. For knee arthroplasty, apixaban was associated with significantly fewer major bleeding events (6496 patients, RR 0.56, 95% confidence interval [CI] 0.32-0.96) and fewer total bleeding events (6496 patients, RR 0.81, 95% CI 0.67-0.97). There were no significant differences in the incidence of major bleeding events (5699 patients, RR 1.40, 95% CI 0.56-3.52) or in the incidence of total bleeding events for rivaroxaban (5699 patients, RR 1.09, 95% CI 0.91-1.30). No differences were found when thromboprophylaxis after hip replacement was the case. Apixaban seems to be associated with a lower risk of the incidence of hemorrhagic events after total knee arthroplasty. For hip arthroplasty, no differences were found between the studied drugs." @default.
• W2126665195 created "2016-06-24" @default.
• W2126665195 creator A5052010496 @default.
• W2126665195 creator A5067324565 @default.
• W2126665195 creator A5079935679 @default.
• W2126665195 date "2011-12-01" @default.
• W2126665195 modified "2023-09-24" @default.
• W2126665195 title "Apixaban and Rivaroxaban Safety After Hip and Knee Arthroplasty" @default.
• W2126665195 cites W1973574476 @default.
• W2126665195 cites W1985842169 @default.
• W2126665195 cites W2014491911 @default.
• W2126665195 cites W2020538743 @default.
• W2126665195 cites W2022932023 @default.
• W2126665195 cites W2030609897 @default.
• W2126665195 cites W2033462150 @default.
• W2126665195 cites W2036506340 @default.
• W2126665195 cites W2037548992 @default.
• W2126665195 cites W2043375058 @default.
• W2126665195 cites W2047247186 @default.
• W2126665195 cites W2057065644 @default.
• W2126665195 cites W2059928999 @default.
• W2126665195 cites W2062272588 @default.
• W2126665195 cites W2066676409 @default.
• W2126665195 cites W2067118403 @default.
• W2126665195 cites W2068476516 @default.
• W2126665195 cites W2087462313 @default.
• W2126665195 cites W2096183924 @default.
• W2126665195 cites W2097827758 @default.
• W2126665195 cites W2100365169 @default.
• W2126665195 cites W2103196751 @default.
• W2126665195 cites W2103247642 @default.
• W2126665195 cites W2107328434 @default.
• W2126665195 cites W2114189419 @default.
• W2126665195 cites W2115513773 @default.
• W2126665195 cites W2122813036 @default.
• W2126665195 cites W2125435699 @default.
• W2126665195 cites W2132299631 @default.
• W2126665195 cites W2133686162 @default.
• W2126665195 cites W2148755831 @default.
• W2126665195 cites W2150567120 @default.
• W2126665195 cites W2151252098 @default.
• W2126665195 cites W2163353989 @default.
• W2126665195 cites W2281239368 @default.
• W2126665195 cites W4242131907 @default.
• W2126665195 cites W4251735950 @default.
• W2126665195 cites W5340607 @default.
• W2126665195 doi "https://doi.org/10.1177/1074248411427402" @default.
• W2126665195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22134134" @default.
• W2126665195 hasPublicationYear "2011" @default.
• W2126665195 type Work @default.
• W2126665195 sameAs 2126665195 @default.
• W2126665195 citedByCount "20" @default.
• W2126665195 countsByYear W21266651952012 @default.
• W2126665195 countsByYear W21266651952013 @default.
• W2126665195 countsByYear W21266651952014 @default.
• W2126665195 countsByYear W21266651952015 @default.
• W2126665195 countsByYear W21266651952016 @default.
• W2126665195 countsByYear W21266651952017 @default.
• W2126665195 countsByYear W21266651952018 @default.
• W2126665195 countsByYear W21266651952019 @default.
• W2126665195 countsByYear W21266651952020 @default.
• W2126665195 countsByYear W21266651952021 @default.
• W2126665195 countsByYear W21266651952022 @default.
• W2126665195 crossrefType "journal-article" @default.
• W2126665195 hasAuthorship W2126665195A5052010496 @default.
• W2126665195 hasAuthorship W2126665195A5067324565 @default.
• W2126665195 hasAuthorship W2126665195A5079935679 @default.
• W2126665195 hasConcept C120665830 @default.
• W2126665195 hasConcept C121332964 @default.
• W2126665195 hasConcept C126322002 @default.
• W2126665195 hasConcept C141071460 @default.
• W2126665195 hasConcept C2776301958 @default.
• W2126665195 hasConcept C2778336525 @default.
• W2126665195 hasConcept C2778661090 @default.
• W2126665195 hasConcept C2779161974 @default.
• W2126665195 hasConcept C2780638905 @default.
• W2126665195 hasConcept C44249647 @default.
• W2126665195 hasConcept C61511704 @default.
• W2126665195 hasConcept C71924100 @default.
• W2126665195 hasConcept C82789193 @default.
• W2126665195 hasConcept C95190672 @default.
• W2126665195 hasConceptScore W2126665195C120665830 @default.
• W2126665195 hasConceptScore W2126665195C121332964 @default.
• W2126665195 hasConceptScore W2126665195C126322002 @default.
• W2126665195 hasConceptScore W2126665195C141071460 @default.
• W2126665195 hasConceptScore W2126665195C2776301958 @default.
• W2126665195 hasConceptScore W2126665195C2778336525 @default.
• W2126665195 hasConceptScore W2126665195C2778661090 @default.
• W2126665195 hasConceptScore W2126665195C2779161974 @default.
• W2126665195 hasConceptScore W2126665195C2780638905 @default.
• W2126665195 hasConceptScore W2126665195C44249647 @default.
• W2126665195 hasConceptScore W2126665195C61511704 @default.
• W2126665195 hasConceptScore W2126665195C71924100 @default.
• W2126665195 hasConceptScore W2126665195C82789193 @default.
• W2126665195 hasConceptScore W2126665195C95190672 @default.
• W2126665195 hasIssue "3" @default.
• W2126665195 hasLocation W21266651951 @default.
• W2126665195 hasLocation W21266651952 @default.

• next